Petefészekrák: nyitott vizsgálatok itt: Mexikó

• NCT05879926

  Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

  Kísérleti kezelés · 3. fázis · NRG Oncology

  Instituto Nacional De Cancerologia de Mexico, Mexico City

  Regiszter frissítve: 2026-11-04

• NCT07213804

  A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

  Kísérleti kezelés · 3. fázis · Eli Lilly and Company

  Scientia Investigacion Clinica S.C., Chihuahua City · Higiea Oncologia, Mexico City · Health Pharma Professional Research S.A. de C.V., Mexico City · INCAN, Mexico City · Unidad Médica Onco-hematológica, Puebla City · Hospital Angeles, Tijuana

  Regiszter frissítve: 2026-11-04

• NCT06330064

  A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

  Kísérleti kezelés · 1/2. fázis · Daiichi Sankyo

  Medical Care & Research Sa de Cv, Mérida · Centro de Atenciă"N E Investigaciă"N Clă Nica En Oncologă A, Mérida · Cryptex Investigacion Clinica S.A. de C.V., México

  Regiszter frissítve: 2026-10-26

• NCT05645536

  Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study

  Kísérleti kezelés · 3. fázis · Tolmar Inc.

  CIMET Scientific Corporation S. A. P. I. de C. V., Guadalajara · Amiisto Atencion Medica Integral, Investigacion Y Terapia Oncologica S. A. DE C. V., Madero · Atencion Medica Integral E Investigacion en Terapia Oncologica, Mexico City · Unidad de Medicina Especializada SMA, San Juan del Río · FAICIC S de RL de C.V., Veracruz

  Regiszter frissítve: 2026-10-23

• NCT06824467

  A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

  Kísérleti kezelés · 3. fázis · Merck Sharp & Dohme LLC

  Centro de Investigación Oncológica Galerías SC (Site 1720), Aguascalientes · Cryptex Investigación Clínica S.A. de C.V. (Site 1715), Cuauhtémoc · CIO - Centro de Inmuno-Oncología de Occidente (Site 1719), Guadalajara · Higiea Oncologia (Site 1713), Mexico City · COI Centro Oncologico Internacional S.A.P.I. de C.V. (Site 1717), Mexico City · Servicios de Oncología Médica Integral - Monterrey (Site 1712), Monterrey · I CAN ONCOLOGY CENTER S.A. DE C.V. (Site 1716), Monterrey · Laboratorio de Patología Clínica del Hospital Universitario "Dr. José Eleuterio González" (Site 1711), Monterrey · Centro de Investigacion Clinica de Oaxaca (Site 1714), Oaxaca City

  Regiszter frissítve: 2026-10-13

• NCT04575935

  Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

  Kísérleti kezelés · 3. fázis · M.D. Anderson Cancer Center

  Instituto Nacional de Cancerología (Mexico), Tlalpan

  Regiszter frissítve: 2026-09-14

• NCT07539844

  Study to Assess Prevalence of the Folate Receptor Alpha (FRa) in Adult Female Participants With Ovarian Cancer in Intercontinental (InterCon) Countries

  Kutatás · AbbVie

  Mexico - Generic Institution /ID# 281928, Mexico City · Mexico - Generic Institution /ID# 281930, Mexico City · Mexico - Generic Institution /ID# 281927, Mexico City

  Regiszter frissítve: 2026-09-14

• NCT07771400

  Molecular Ovarian Cancer Assessment in LatiNoAmerican PAtients

  Kutatás · Latin American Cooperative Oncology Group

  Hospital Ángeles Pedregal, Mexico City · INCan - Instituto Nacional de Cancerología, Mexico City · TecSalud (Tecnológico de Monterrey), Nuevo León

  Regiszter frissítve: 2026-08-25

• NCT04294927

  TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention

  Kísérleti kezelés · University Medical Center Nijmegen

  Instituto Nacional de Cancerologia, Mexico City

  Regiszter frissítve: 2026-04-06

• NCT06883409

  Laparoscopic Interval Cytoreductive Surgery in Advance Ovarian Cancer

  Kísérleti kezelés · Instituto Nacional de Cancerologia de Mexico

  Instituto Nacional de Cancerologia, México

  Regiszter frissítve: 2025-03-26

• NCT03275194

  HIPEC in Ovarian Carcinoma Clinical Stage IIIC and IV During Interval Laparotomy

  Kísérleti kezelés · 2. fázis · Instituto Nacional de Cancerologia de Mexico

  National Cancer Institute of Mexico, Mexico City

  Regiszter frissítve: 2023-04-28

Minden vizsgálat (Petefészekrák) és a térkép

Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.

Hibát jelzek